Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1681/ASN.2013060665 http://scihub22266oqcxt.onion/10.1681/ASN.2013060665 C4033373!4033373 !24511138     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\24511138 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       J+Am+Soc+Nephrol 2014 ; 25 (6 ): 1226-35 Nephropedia Template TP {{tp|p=24511138 |t=2014. Renalase prevents AKI independent of amine oxidase activity |pdf=|usr=}}{{24511138 }} gab.com Text Renalase prevents AKI independent of amine oxidase activity JO: J Am Soc Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=24511138 #FOAvip AKI is characterized by increased catecholamine levels and hypertension. Renalase, a secretory flavoprotein that oxidizes catecholamines, attenuates ischemic injury and the associated increase in catecholamine levels in mice. However, whether the amine oxidase activity of renalase is involved in preventing ischemic injury is debated. In this study, recombinant renalase protected human proximal tubular (HK-2) cells against cisplatin- and hydrogen peroxide-induced necrosis. Similarly, genetic depletion of renalase in mice (renalase knockout) exacerbated kidney injury in animals subjected to cisplatin-induced AKI. Interestingly, compared with the intact renalase protein, a 20-amino acid peptide (RP-220), which is conserved in all known renalase isoforms, but lacks detectable oxidase activity, was equally effective at protecting HK-2 cells against toxic injury and preventing ischemic injury in wild-type mice. Furthermore, in vitro treatment with RP-220 or recombinant renalase rapidly activated Akt, extracellular signal-regulated kinase, and p38 mitogen-activated protein kinases and downregulated c-Jun N-terminal kinase. In summary, renalase promotes cell survival and protects against renal injury in mice through the activation of intracellular signaling cascades, independent of its ability to metabolize catecholamines, and we have identified the region of renalase required for these effects. Renalase and related peptides show potential as therapeutic agents for the prevention and treatment of AKI. Twit Text FOAVip Renalase prevents AKI independent of amine oxidase activity ????J Am Soc Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=24511138 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24511138 #FOAvip English Wikipedia <ref>{{Cite pmid|24511138 }}</ref> Renalase prevents AKI independent of amine oxidase activity #MMPMID24511138 Wang L ; Velazquez H ; Moeckel G ; Chang J ; Ham A ; Lee HT ; Safirstein R ; Desir GV J Am Soc Nephrol 2014[Jun]; 25 (6 ): 1226-35 PMID24511138 show ga AKI is characterized by increased catecholamine levels and hypertension. Renalase, a secretory flavoprotein that oxidizes catecholamines, attenuates ischemic injury and the associated increase in catecholamine levels in mice. However, whether the amine oxidase activity of renalase is involved in preventing ischemic injury is debated. In this study, recombinant renalase protected human proximal tubular (HK-2) cells against cisplatin- and hydrogen peroxide-induced necrosis. Similarly, genetic depletion of renalase in mice (renalase knockout) exacerbated kidney injury in animals subjected to cisplatin-induced AKI. Interestingly, compared with the intact renalase protein, a 20-amino acid peptide (RP-220), which is conserved in all known renalase isoforms, but lacks detectable oxidase activity, was equally effective at protecting HK-2 cells against toxic injury and preventing ischemic injury in wild-type mice. Furthermore, in vitro treatment with RP-220 or recombinant renalase rapidly activated Akt, extracellular signal-regulated kinase, and p38 mitogen-activated protein kinases and downregulated c-Jun N-terminal kinase. In summary, renalase promotes cell survival and protects against renal injury in mice through the activation of intracellular signaling cascades, independent of its ability to metabolize catecholamines, and we have identified the region of renalase required for these effects. Renalase and related peptides show potential as therapeutic agents for the prevention and treatment of AKI. |Acute Kidney Injury/*drug therapy/*metabolism/pathology [MESH] |Amine Oxidase (Copper-Containing)/metabolism [MESH] |Animals [MESH] |Antineoplastic Agents/toxicity [MESH] |Apoptosis/drug effects/physiology [MESH] |Cell Line [MESH] |Cisplatin/toxicity [MESH] |Humans [MESH] |Kidney Tubules, Proximal/cytology/*drug effects/*enzymology [MESH] |MAP Kinase Signaling System/drug effects/physiology [MESH] |Male [MESH] |Mice [MESH] |Mice, Inbred C57BL [MESH] |Mice, Knockout [MESH] |Monoamine Oxidase/*metabolism/*pharmacology [MESH] |Oxidants/toxicity [MESH] |Proto-Oncogene Proteins c-akt/metabolism [MESH]Renalase prevents AKI independent of amine oxidase activity (epmc).pdf DeepDyve Pubget Overpricing